OGT Announce the Second in a series of Japanese Licensing Agreements

Oxford Gene Technology (OGT) has announce the second in a series of Japanese licensing agreements giving Yamatake Corporation access to OGT’s “Southern array patents”, the fundamental patents covering the manufacture and commercialisation of oligonucleotide microarrays.
           
This microarray license will enable Yamatake to manufacture gemkey™ microarrays using in-situ synthesis and market them, via its distributor Sigma-Aldrich Japan K.K.       

 Dr Michael Bennett, Vice President Licensing Asia at OGT, said: “This is the one of several Japanese companies that has been in licensing discussions with OGT. Yamatake is the only Japanese company using in-situ synthesis, and OGT is happy to support this technology by granting a license.”          
             
The licence will remain valid for the patents’ lifetime. Financial details were not disclosed.